Article Information
- Received August 4, 2021
- Revision received November 28, 2022
- Accepted December 1, 2022
- Published online December 6, 2022.
Author Information
- 1Department of Physiology and Cellular Biophysics, Columbia University, New York, NY 10032
- 2Department of Neurology, Columbia University, New York, NY 10032
- 3Department of Otolaryngology-Head and Neck Surgery, Columbia University, New York, NY 10032
- 4Nestlé Research, 1000, Lausanne, Switzerland
- 5Oral and Maxillofacial Surgery, New York Presbyterian, Columbia University, New York, NY 10032
- Correspondence should be addressed to Yalda Moayedi at moayediyalda{at}gmail.com.
Author contributions
Author contributions: Y.M., S.M., M.P., A.K., and E.A.L. designed research; Y.M. and M.P. performed research; Y.M. contributed unpublished reagents/analytic tools; Y.M., S.M., and E.A.L. analyzed data; Y.M. wrote the paper.
Disclosures
S.M. was an employee of Sociétés des Produits Nestlé S.A. All other authors declare no competing financial interests.
This work was supported by Société des Produits Nestlé SA; the Berrie Foundation Initiative on the Neurobiology of Obesity (E.A.L., Y.M.); the Thompson Family Foundation Initiative on Chemotherapy Induced Peripheral Neuropathy and Sensory Neuroscience (Y.M.); and the National Institutes of Health Grant NIAMS R01AR051219 (to E.A.L.). Imaging was performed with support from the Zuckerman Institute’s Cellular Imaging Platform. Human foreskin samples were collected with support from the Columbia University Skin Disease Resource‐Based Center (epiCURE, P30AR069632).
Funding
SPN, SA
Berrie Foundation Initiative on the Neurobiology of Obesity
Thompson Family Foundation Initiative on Chemotherapy Induced Peripheral Neuropathy and Sensory Neuroscience
HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
R01AR051219
Other Version
- You are viewing the most recent version of this article.
- previous version (December 06, 2022).
Online Impact